Back
Biogen Stock Predictions
Sell
45
BIIB
Biogen
Last Price:
230.59
Seasonality Move:
6.74%
7 Day Trial
ALL ACCESS PASS
$
7
Biogen Stock Forecast
- Over the next 52 weeks, Biogen has on average historically risen by 39.3% based on the past 32 years of stock performance.
- Biogen has risen higher in 20 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Biogen Stock Undervalued?
The current Biogen [BIIB] share price is $230.57. The Score for BIIB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Biogen Stock Go Up Next Year?
- Over the next 52 weeks, Biogen has on average historically risen by 39.3% based on the past 32 years of stock performance.
Biogen Stock Rating
Sell
45
Biogen (BIIB)
is a Sell
Is Biogen overpriced?
- Biogen has risen higher in 20 of those 32 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Biogen Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
319.76
52-Week Low:
189.44
Prediction Charts
Market Cap:
33.57B
Price in USD:
230.57
Volume:
983.98K
Beta:
0.94
Technical Analysis
SMA50:
213.10
SMA100:
226.81
SMA200:
239.51
52-Wk Change:
-24.71%
Stock Predictions
-
Is Biogen stock public?
Yes, Biogen is a publicly traded company. -
What is the Biogen stock quote today?
The Biogen stock price is 230.57 USD today. -
How to buy Biogen stock online?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 214.66 | 214.82 | 217.73 | 213.58 |
May-1 | 215.56 | 216.13 | 218.66 | 214.70 |
May-2 | 217.99 | 213.51 | 218.46 | 213.14 |
May-3 | 215.30 | 217.51 | 217.88 | 213.11 |
May-6 | 219.23 | 221.41 | 222.40 | 218.29 |
May-7 | 221.52 | 219.04 | 221.98 | 216.08 |
May-8 | 218.00 | 219.72 | 221.53 | 217.00 |
May-9 | 220.67 | 222.87 | 222.91 | 218.89 |
May-10 | 222.76 | 221.50 | 223.95 | 220.01 |
May-13 | 223.00 | 225.34 | 225.58 | 221.72 |
May-14 | 226.10 | 226.88 | 227.30 | 222.01 |
May-15 | 228.98 | 235.32 | 236.90 | 228.66 |
May-16 | 231.60 | 230.04 | 234.58 | 228.07 |
May-17 | 229.42 | 230.57 | 230.83 | 226.43 |
Biogen Earnings
Biogen Earnings Report: Per Share Biogen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen Forecast Revenue Growth
Biogen Stock Analysis: Historical quarterly revenues per share for Biogen and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $1.74 per share.
* Biogen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.